Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA‐REG OUTCOME trial

AIM: To evaluate the effect of empagliflozin on uric acid (UA) levels, antigout medication and gout episodes in the EMPA‐REG OUTCOME trial (NCT01131676). MATERIALS AND METHODS: A total of 7020 patients with type 2 diabetes (T2D) were randomized to either empagliflozin (10 or 25 mg) or placebo. The e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, João Pedro, Inzucchi, Silvio E., Mattheus, Michaela, Meinicke, Thomas, Steubl, Dominik, Wanner, Christoph, Zinman, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293326/
https://www.ncbi.nlm.nih.gov/pubmed/34558768
http://dx.doi.org/10.1111/dom.14559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293326/
https://www.ncbi.nlm.nih.gov/pubmed/34558768
http://dx.doi.org/10.1111/dom.14559

Ejemplares similares